Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6189730 | Brachytherapy | 2013 | 9 Pages |
Abstract
Using postimplant dosimetry data, the TCP model was able to predict for freedom from biochemical failure. The cutpoint value that would be used clinically depends on the selection of the model parameters, but the potential for the model to be used in the optimization of treatment planning is demonstrated.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Annette Haworth, Scott Williams, Hayley Reynolds, David Waterhouse, Gillian M. Duchesne, Joseph Bucci, David Joseph, Sean Bydder, Martin Ebert,